Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, has announced that ResolutionMD® is first to receive certification from the China Food and Drug Administration (CFDA) for diagnosis on both web and mobile devices for all imaging modalities.
This certification enables medical practitioners in China to take advantage of the benefits of mobile diagnosis to improve patient care as they can now access a range of image storage systems and diagnostic tool sets on-the-go.
Calgary Scientific worked closely with the CFDA to conduct onsite testing at a CFDA testing center and passed several phases of complex review. Obtaining the Import Medical Device Registration Certificate in China means healthcare organisations can feel confident using ResolutionMD, the world’s leading enterprise image-viewing solution, to perform a clinical diagnosis on web, iOS or Android devices.
"Obtaining this CFDA certification is another significant milestone for Calgary Scientific and is a huge step towards our growth in the Chinese market,” said Pierre Lemire, President and CTO of Calgary Scientific. “Mobile imaging is a trend that is starting to take off in China and now that ResolutionMD has the CFDA accreditation, our partners can deliver the benefits of mobility to healthcare enterprises, enabling dramatic improvements to patient outcomes.”
22 April 2014
Latest Articles
Imaging, IT solutions, Calgary Scientific, FDA, image sharing, mobile imaging, image storing, mobile diagnosis
Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, has announced that ResolutionMD® is f...
